dont really want to get into it but please someone correct

New Post Public Reply Private Reply Replies (1) Message Board
seemingly-harmless dfwl28 #160906
675
dont really want to get into it but please someone correct me if im wrong

directly from the "marketing department" -

used to be called "flu shots" and are now called "flu vaccines"

just like ufos are now uaps

marketing - directly from the "marketing department"

"vaccines" eliminate the ability for the "polio virus" to
- infect the person
- and therefore also prevent the spread to another person


covid and flu "vaccines" do neither of this. they
- reduce the effects of the virus, and do not prevent actual infection
- since the person still gets infected with covid but the symptoms are greatly reduced (sometimes not always -ahem- certainly not in my case covid destroyed me), the virus is still spread to others

so why are they still called "vaccines"

the few years i got the flu "vaccine", i got the flu on top of the shot making me sick so....i will opt for "never again"

they are "treatments"
they are "shots"
they are NOT "vaccines"


so straight from the "marketing department" we get " there arent enough employees to release the pfizer vax data so it would take 75 years to do so... sorry guys... oops...our bad...see ya in 75 years...NEXT!!!" is a little convenient and wreaks of collusion. par for the course from these people

Quote:
Pfizer getting a bum's rap? FDA was the source of the 75 year timeline. per AI

The claim that Pfizer and the FDA tried to "hide" vaccine results for 75 years refers to a 2021 legal dispute over a Freedom of Information Act (FOIA) request. Here is the breakdown of what actually occurred:
Reuters
Reuters
+1
The 75-Year Timeline: This was a processing estimate provided by the FDA, not a secret "hiding" period. The agency argued that its small FOIA office (10 employees) could only review and redact sensitive personal information from the roughly 450,000 pages of data at a rate of 500 pages per month. At that pace, full disclosure would have taken approximately 75 years.
Court Intervention: In January 2022, a federal judge in Texas rejected this timeline, ruling that the release was of "paramount public importance". He ordered the FDA to drastically accelerate the process, requiring the release of 55,000 pages every 30 days. Most of the documents were subsequently released within eight months.
"mRNA Gene Therapy": While mRNA technology involves genetic instructions, it is legally and scientifically classified as a vaccine, not gene therapy. Regulatory agencies like the FDA and CDC distinguish mRNA vaccines because they do not enter the cell nucleus or alter a person's DNA.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AIM-T1 Wins at CES 2027, Paving AI in Electronics

Updated Category News Views 41

AIM-T1: A Game-Changer for Electronics Manufacturing You ever wonder how a single gizmo could shake up the entire electronics manufacturing world? Well, A.I.Matics' AIM-T1 has done just that by snagging two coveted CES Innovation Awards for 2027. In the cutthroat arenas of Artificial Intelligence and Construction & Industrial Tech, this platform's getting the spotlight...

Continue Reading
LASEROPTEK Embraces CPT Clarity: Impacts on Dermatology

Updated Category News Views 130

CPT Changes: A New Era for Dermatology? Get this: the American Medical Association's revisions to the CPT codes could be just the spark LASEROPTEK's been waiting for. Landing on the desk is the 2027 Current Procedural Terminology (CPT) code set which clarifies how docs report targeted UVB laser treatments. We're talking about codes 96920–96922, now clear as crystal,...

Continue Reading
Bright Start 529 Nails 8th Gold Rating: A Game Changer

Updated Category News Views 89

Gold Again: The Bright Start 529 Legacy Shining brightly for the eighth consecutive time, Illinois' Bright Start 529 College Savings Plan has snagged yet another Gold rating from Morningstar. That's no small feat folks, especially in a landscape where nine Gold ratings grace the entire roster of 529 plans in the country. Illinois' treasure chest plan under Treasurer...

Continue Reading
Greenberg Traurig Shareholders Earn Law360 MVP Honors

Updated Category News Views 52

A Spotlight on Legal Excellence In the tough-as-nails world of legal battles, a select few rise above the rest, but it's not every day you see three folks from the same shop getting the nod as MVPs. That's the story coming out of Greenberg Traurig, where shareholders Gregory A. Fishman, Michael J. Thomas, and David B. Weinstein made the cut for the 2026 Law360 MVP honors....

Continue Reading
Greenberg Traurig Secures Top Honors at LBA Awards

Updated Category News Views 158

A Celebration of Achievements in South Florida Nothing signifies success like a room full of applause and a shiny award, especially when it comes from a community as influential as South Florida's construction scene. This past October, Greenberg Traurig, a heavy hitter in the legal sphere, clinched its title as the Law Firm of the Year from the Latin Builders Association...

Continue Reading
RAI's TrustX Lab Unveils AI Assurance Framework

Updated Category News Views 52

Pushing the Envelope on AI Control Alright, AI wonks, the Responsible AI Institute just introduced a new sheriff in town. It's called the TrustX Assurance Lab, and it was rolled out during RAISE 2026. We're talking about an independent setup designed to answer whether autonomous AI can stay within its limits. Who's involved? A lot of brainpower from member organizations...

Continue Reading
Lindian Secures Key Offtake for Rare Earths Expansion

Updated Category News Views 54

Lindian Resources Drives New Deal in Rare Earths Ah, the sweet smell of another strategic move in the resources game. Lindian Resources Limited is strutting its stuff down under by securing a binding offtake for a hefty 30,000 tonnes of Monazite Concentrate. Now, that's a weighty lift in the world of rare earths, and it kicks off just in time for their December production...

Continue Reading
ResMed Faces Probe: Potential Breach Alert for Investors

Updated Category News Views 107

Cracks Surfacing at ResMed? Alright, folks, ResMed Inc. (NYSE: RMD) is facing a bit of heat these days. We're talking about a shareholder alert as Levi & Korsinsky, noted legal hounds when it comes to financial misconduct, have decided to dig deep into ResMed. They're looking to uncover any possible breaches of fiduciary duties by some of the top brass at this sleep apnea...

Continue Reading
Stellus Capital Delivers Solid Q3 Amid Turbulent Times

Updated Category News Views 106

Unpacking Stellus Capital's Latest Quarter Boy, Stellus Capital sure knows how to keep us on our toes. In a landscape where many are still reeling from the latest market tremors, they post some solid Q3 numbers for September 30, 2026. Not without its hiccups, but hey, who isn’t stumbling a bit right now? Financial Snapshot: Stability Amidst Uncertainty Stellus reported...

Continue Reading
LG Wins CES Honor with Breakthrough Battery Diagnostic Tech

Updated Category News Views 204

Speeding Up Diagnostics: A Major Leap Forward In a world where every second counts, LG Energy Solution strikes gold with their latest innovation, Re.Pulse. CES Innovation Awards 2027 has honored LG for this slick piece of tech that trims down battery diagnosis time from a snail's pace seven hours to a lightning-fast 10 minutes. It's not just about speed—it’s also...

Continue Reading

Top 5 Most Recently Viewed Articles

Xsolla Unveils Xsolla ZK: A New Era for Web3 Gaming

Updated Category News Views 233

Xolla Takes a Bold Step into Web3 with Xsolla ZK In a groundbreaking move, Xsolla has announced its intention to launch Xsolla ZK, which aims to revolutionize the video game industry by harnessing the power of blockchain technology. This innovative platform will feature a digital backpack that allows game developers and item creators to store and manage in-game assets...

Continue Reading
Titan Machinery Strategically Exits German Dealership Market

Updated Category News Views 237

Titan Machinery's German Dealership Divestiture Plans Titan Machinery Inc. (Nasdaq: TITN), recognized as a prominent network of agricultural and construction equipment stores, has made a significant announcement regarding its dealership operations in Germany. This decision reflects the company’s strategy to optimize its global operations and maximize returns. The...

Continue Reading
Analyzing Ally Financial: A Comprehensive Stock Outlook

Updated Category News Views 207

Exploring Ally Financial's Landscape and Future Ally Financial Inc. (NYSE: ALLY) is a forward-thinking digital financial services firm that excels in automotive finance. As the company navigates a fluctuating market, it showcases a dynamic blend of opportunities and challenges. The eyes of investors and market analysts remain on Ally as it adapts and evolves through...

Continue Reading
Globe Life Receives Closure on DOJ Investigation, Focuses on Growth

Updated Category News Views 118

Globe Life Concludes DOJ Investigation and Looks Ahead Globe Life Inc. (NYSE: GL) has recently received news from the U.S. Attorney's Office for the Western District that its investigation into the company's practices has been officially closed. This positive development comes as Globe Life strives to maintain its reputation and growth in the life insurance sector....

Continue Reading
Recent Insider Sale at Gartner Inc Sparks Investor Interest

Updated Category News Views 111

Recent Insider Trading at Gartner Inc In a noteworthy development that has drawn the attention of investors, Claire Herkes, the Executive Vice President of Conferences at Gartner Inc (NYSE: IT), recently sold 478 shares of the company. This transaction took place at a significant price of $506.01 per share, resulting in a total sale value that exceeds $240,000. Insider...

Continue Reading